NCT00573001 - Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA) | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

July 31, 2011

Study Completion Date

December 31, 2011

Conditions

HIV Infections

Interventions

DRUG

Tenofovir/Emtricitabine (Truvada) and Nevirapine

Tenofovir/Emtricitabine(Truvada) 245/200mg 1cp/day ; Nevirapine 200mg 2cp/day after first 14 days

DRUG

Tenofovir/Emtricitabine/Efavirenz (Atripla)

Tenofovir/Emtricitabine/Efavirenz (Atripla) 300/200/600mg 1cp/day

DRUG

Tenofovir (Viread) and Lopinavir/Ritonavir (Aluvia)

Tenofovir (Viread) 300mg 1cp/day ; Lopinavir/Ritonavir (Aluvia) 400/100mg 4cp/day

DRUG

Tenofovir/Emtricitabine (Truvada) and Zidovudine

Tenofovir/Emtricitabine (Truvada) 245/200mg 1cp/day ; Zidovudine 300mg 2cp/day

Trial Locations (2)

Hopital Central, Yaoundé

Hopital de Fann, Dakar